VETERICYN TRIPLE ACTION EAR TREATMENT- hydrocortisone liquid 
INNOVACYN INC.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Active Ingredient

Hydrocortisone

Description

Vetericyn® Ear Treatment is intended for use in removing debris and alleviating itch caused by irritation and inflammation for otitis externa (i.e., outer ear infection).

Dosage/Administration

Shake well. Fill ear canal with product and gently massage the affected area, allowing it to stay inside ear. Wipe away excess liquid. Head shaking after application is common. Repeat once (1) per day for seven (7)days. Consult your veterinarian for extended use.

Warning

Animal use only, not for humans. Keep out of reach of children. Avoid contact with eyes. If condition does not improve after seven (7) days or if irritation or systemic condition develop, stop use and contact your veterinarian. Do not use in conjunction with other ear solutions. Do not use on ruptured ear drum. Avoid water near ears during treatment.

Inactive Ingredient

Benzoic Acid, Benzyl Alcohol, Buffer, Chrysanthemum Indicum Flower Extract, Dehydroacetic Acid, Glycerin,Hydroxypropyl Cellulose, Lysozyme, Phellodendron Chinense Bark Extract, Propylene Glycol, Sorbic Acid, Water.

 Precautions

Store at room temperature. Do not use after expiration date. Cap applicator tip after use. Follow general guidelines for safe medication disposal.

Questions

vetericyn.com | 866.318.3116

Product label

image descriptionimage description

VETERICYN TRIPLE ACTION EAR TREATMENT 
hydrocortisone liquid
Product Information
Product TypeOTC ANIMAL DRUGItem Code (Source)NDC:70489-1023
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HYDROCORTISONE (UNII: WI4X0X7BPJ) (HYDROCORTISONE - UNII:WI4X0X7BPJ) HYDROCORTISONE1 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
GLYCERIN (UNII: PDC6A3C0OX)  
BENZYL ALCOHOL (UNII: LKG8494WBH)  
BENZOIC ACID (UNII: 8SKN0B0MIM)  
SORBIC ACID (UNII: X045WJ989B)  
DEHYDROACETIC ACID (UNII: 2KAG279R6R)  
CHRYSANTHEMUM INDICUM FLOWER (UNII: I6OER6U04L)  
HYDROXYPROPYL CELLULOSE, UNSPECIFIED (UNII: 9XZ8H6N6OH)  
WATER (UNII: 059QF0KO0R)  
LYSOZYME (UNII: 968JKA7T33)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
PHELLODENDRON CHINENSE WHOLE (UNII: QKA3ZK8IIE)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:70489-1023-11 in 1 CARTON
144 mL in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other07/01/2024
Labeler - INNOVACYN INC. (025217003)
Establishment
NameAddressID/FEIBusiness Operations
Westwood Laboratories, LLC.832280635api manufacture

Revised: 5/2024
Document Id: e1c7cd7e-e4d7-4af2-856a-8452b58d7b4a
Set id: 81248fb6-0a7d-44f5-8977-f5362acac0f5
Version: 1
Effective Time: 20240506
 
INNOVACYN INC.